info@invisionmedi.com
Description
Diabetes is one of the most challenging health problems of the 21st century. About 75% live in low- and middle-income countries.
Teneligliptin
- Class of medications: Dipeptidyl peptidase 4 (DPP-4) inhibitor
- Teneligliptin was introduced in India in May 2015 and is available at almost one quarter to one-fifth the cost of other DPP-4 inhibitors (namely sitagliptin, vildagliptin, saxagliptin, and linagliptin).
Composition
Teneligliptin 20 mg
Indications
- Nephropathy
- Neuropathy
- Retinopathy
- Heart diseases